ADOCIA News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.03.14	Adocia confirms positive clinical results for its BioChaperone® Combo, a combination of long-acting insulin glargine and fast-acting insulin lispro (Businesswire)
27.02.14	Adocia Announces Preliminary Positive Clinical Results for its Combination of Long-Acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone® Combo (Businesswire)
18.02.14	ADOCIA: annual revenue of EUR 5.6 M in 2013 (Businesswire)
20.01.14	Half year report on Adocia’s liquidity agreement with DSF Markets (Businesswire)
13.01.14	Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio (Businesswire)
06.01.14	Adocia Launches Phase IIa Clinical Trial for Its Ultra-Fast Acting Formulation of Analog Insulin (Businesswire)
19.12.13	Adocia Announces Its Financial Calendar for 2014 (Businesswire)
09.12.13	Adocia Signs an Exclusive License on a Nanotechnology Which Improves the Efficacy of Anti-Tumoral Agents by Targeting Their Action into Tumors (Businesswire)
13.11.13	Adocia Announces the Initiation of a Clinical Trial on Its Combination of the Long-Acting Insulin Glargine and a Fast-Acting Insulin Analog (Businesswire)
23.10.13	Adocia Announces Revenues of EUR 4.7 M for the Third Quarter of 2013 with No Cash Impact (Businesswire)
05.09.13	Adocia: Activity and results for the first half of 2013 (Businesswire)
29.07.13	Adocia Reacquires Exclusive Development Rights to Ultra-Fast Acting Insulin Analog (Businesswire)
15.07.13	Half Year Report on Adocia’s Liquidity Agreement With BIL Finance (Businesswire)
14.01.13	Half year report on Adocia’s liquidity agreement with BIL Finance (Businesswire)
07.01.13	Adocia announces its financial calendar for 2013 as well as its participation to upcoming investor conferences. (Businesswire)
30.10.12	ADOCIA announces the strong growth of its turnover (Businesswire)
22.10.12	Adocia is extending its intellectual property to new formulations of monoclonal antibodies (Businesswire)
03.09.12	Adocia: Financial Results and Business Report for the First Half of 2012 (Businesswire)
13.06.12	Adocia announces a strengthened intellectual property on its lead project for its chronic wounds treatment (Businesswire)
26.04.12	ADOCIA: Revenue of 1st quarter 2012 (Businesswire)
23.04.12	ADOCIA reports positive phase II clinical results for the treatment of diabetic foot ulcer (Businesswire)
02.04.12	ADOCIA: 2011 Annual Financial Results (Businesswire)
15.03.12	ADOCIA Increases the Size of Its Initial Public Offering to €27.4 Million Through the Partial Exercise of the Overallotment Option (Businesswire)
29.02.12	ADOCIA: Strong Growth in Operating Income in 2011 (Businesswire)
28.02.12	ADOCIA Reports Positive Phase IIa Clinical Results on Its Fast-Acting Human Insulin, HinsBet®: the First Clinical Results Are Confirmed on Diabetic Patients (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	536.00	0.94 %	K V
Sonova Hldg	307.00	0.79 %	K V
Kuehne+Nagel Int	209.50	0.43 %	K V
Roche Hldg G	252.30	0.36 %	K V
Alcon	77.88	0.33 %	K V
UBS Group	27.61	-0.54 %	K V
ABB	49.25	-0.59 %	K V
Sika	226.80	-0.79 %	K V
CieFinRichemont	121.35	-0.82 %	K V
Logitech Intl	70.72	-1.75 %	K V

Nachrichten zu ADOCIA

Aktien Top/Flop

Meistgelesene Nachrichten